Financial Performance - Net sales for the three months ended January 3, 2026, increased by $93.8 million, or 9.6%, compared to the same period in 2024, reaching $1,069.9 million[83]. - Operating income for the three months ended January 3, 2026, increased by $7.6 million, or 16.2%, to $54.5 million, with an operating margin of 5.1%[94]. - Net income for the three months ended January 3, 2026, rose by $3.9 million, or 10.5%, to $41.2 million, primarily due to increased operating income[99]. - Diluted earnings per share increased to $1.51 for the three months ended January 3, 2026, up from $1.34 in the prior year[100]. Segment Performance - In the AMER segment, net sales increased by $70.9 million, or 25.9%, driven by production ramps of new products and increased customer demand[86]. - In the APAC segment, net sales increased by $4.6 million, or 0.8%, with production ramps partially offset by customer disengagements[87]. - In the EMEA segment, net sales increased by $17.2 million, or 17.0%, attributed to production ramps of new products[88]. Profitability and Margins - Gross profit for the three months ended January 3, 2026, increased by $5.4 million, or 5.4%, with a gross margin of 9.9%, down 40 basis points from the previous year[93]. - Cost of sales increased by $88.3 million, or 10.1%, primarily due to higher material and component costs[91]. Cash Flow and Liquidity - Cash and cash equivalents as of January 3, 2026, were $249.4 million, down from $306.8 million as of September 27, 2025[106]. - Cash flows used in operating activities for the three months ended January 3, 2026, were $(15.4) million, compared to $53.6 million for the same period in 2024[108]. - Free Cash Flow (FCF) for the three months ended January 3, 2026, was $(50.6) million, a decrease of $77.7 million compared to $27.1 million for the same period in 2024[114]. - Cash flows used in investing activities increased to $35.1 million for the three months ended January 3, 2026, from $26.4 million in the same period in 2024[117]. - Cash flows used in financing activities were $8.0 million for the three months ended January 3, 2026, compared to $52.8 million for the same period in 2024[119]. Capital Expenditures and Investments - Capital expenditures for fiscal 2026 are estimated to be approximately $100.0 million to $120.0 million to support new program ramps and replace older equipment[118]. - As of January 3, 2026, 91% of cash and cash equivalents were held outside the U.S. by foreign subsidiaries[107]. - The company has a share repurchase program with $62.6 million of authority remaining under the 2026 Program as of January 3, 2026[121]. Currency and Interest Rate Risks - As of January 3, 2026, 10% of net sales and 17% of total costs were denominated in currencies other than the U.S. dollar[132]. - A 10.0% change in the value of the U.S. dollar relative to other transactional currencies would not have a material effect on the company's financial position, results of operations, or cash flows[132]. - The only material interest rate risk as of January 3, 2026, was associated with the Credit Facility, which has various interest rate options based on different benchmarks[134]. - The borrowing rate under the Credit Facility was SOFR plus 1.00% as of January 3, 2026[135]. - Borrowings under the 2018 NPA are based on a fixed interest rate, mitigating much of the company's interest rate risk[135]. - A 10.0% change in interest rates would not have a material effect on the company's financial position, results of operations, or cash flows[135].

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are ...

U.S. stocks settled lower on Friday, with the Nasdaq Composite falling more than 200 points during the session. The S&P 500 recorded losses for the third straight session, but recorded a gain for January.The Dow Jones closed lower by around 179 points to 48,892.47 on Friday. The S&P 500 fell 0.43% to 6,939.03, while the Nasdaq Composite dipped 0.94% at 23,461.82 during Friday's session.The S&P 500 gained 1.4%, while the Dow added 1.7%, for January. The Nasdaq recorded a monthly gain of 1%.Wall Street analys ...

Group 1 - Benchmark raised the price target on Plexus (PLXS) to $220 from $195, maintaining a Buy rating on the shares [1] - The firm was surprised by the strength of the Q2 guidance and the upbeat tone around demand momentum for the remainder of FY26 and beyond [1]

Core Insights - Plexus Corp (PLXS) reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.78, surpassing the previous year's $1.73 and beating the Zacks Consensus Estimate of $1.77 per share [1][7] - Revenues reached $1.07 billion, reflecting a year-over-year increase of 9.6%, although it slightly missed the Zacks Consensus Estimate of $1.071 billion [1][7] - Management anticipates non-GAAP EPS to be in the range of $1.66-$1.81 and revenues between $1.05 billion and $1.09 billion for the upcoming quarter [1] Revenue Breakdown - Revenues from the Americas increased by 25.9% to $345 million, while revenues from EMEA and Asia-Pacific rose by 16.8% and 0.8%, respectively [2] - The company secured 22 manufacturing program wins, projected to contribute $283 million in annualized revenues once fully operational [2][7] Growth Outlook - Management indicated that program wins, market share gains, and increasing demand position the company to potentially exceed its revenue growth target of 9% to 12% for fiscal 2026 [3] - For the second quarter of fiscal 2026, revenues are expected to be between $1.11 billion and $1.15 billion, with non-GAAP operating margin anticipated to be between 5.6% and 6% [15] Segment Performance - Aerospace/Defense revenues grew by 11.3% year over year to $178 million, contributing 17% to total revenues [5] - Healthcare/Life Sciences revenues increased by 24.6% year over year to $466 million, accounting for 43% of total revenues [9] - Industrial sector revenues decreased by 3.6% year over year to $426 million, contributing 40% to total revenues [10] Financial Metrics - Gross profit on a GAAP basis rose by 5.4% year over year to $106.2 million, with a gross margin of 9.9%, down from 10.3% in the previous year [12] - Cash and cash equivalents stood at $248.8 million as of January 3, 2026, down from $306.5 million as of September 27, 2025 [13] - The company reported a negative free cash flow of $50.6 million after capital expenditures of $35.2 million [14]

Plexus (NasdaqGS:PLXS) Q1 2026 Earnings call January 29, 2026 08:30 AM ET Company ParticipantsOliver Mihm - EVP and COOPatrick Jermain - EVP and CFOShawn Harrison - Head of Investor RelationsTodd Kelsey - CEOConference Call ParticipantsAnja Soderstrom - Senior Equity Research AnalystDavid Williams - Equity Research AnalystJames Ricchiuti - AnalystMelissa Fairbanks - Vice President and Equity Research AnalystSteve Barger - AnalystOperatorI will now hand the call over to Shawn Harrison, Vice President of Inve ...

Plexus (NasdaqGS:PLXS) Q1 2026 Earnings call January 29, 2026 08:30 AM ET Company ParticipantsOliver Mihm - EVP and COOPatrick Jermain - EVP and CFOShawn Harrison - Head of Investor RelationsTodd Kelsey - CEOConference Call ParticipantsAnja Soderstrom - Senior Equity Research AnalystDavid Williams - Equity Research AnalystJames Ricchiuti - AnalystMelissa Fairbanks - Vice President and Equity Research AnalystSteve Barger - AnalystAnja SoderstromI will now hand the call over to Shawn Harrison, Vice President ...

Plexus (NasdaqGS:PLXS) Q1 2026 Earnings call January 29, 2026 08:30 AM ET Speaker0I will now hand the call over to Shawn Harrison, Vice President of Investor Relations. Please go ahead.Speaker6Good morning, and thank you for joining us today. Some of the statements made and information provided during our call today will be forward-looking statements, including without limitation, those regarding revenue, gross margin, selling and administrative expense, operating margin, other income and expense, taxes, ca ...

FISCAL FIRST QUARTER 2026 HIGHLIGHTS January 28, 2026 PLEXUS CONFIDENTIAL FISCAL FIRST QUARTER THEMES Program wins, share gains and improving market demand position Plexus in F26 to meet or exceed high end of 912% revenue growth goal. Forecast strong F26 operating leverage inclusive of investments in talent, technology, facilities and advanced capabilities. PLEXUS CONFIDENTIAL SAFE HARBOR AND FAIR DISCLOSURE STATEMENT Some of the statements made and information provided during our call as well as informatio ...

Plexus (PLXS) reported $1.07 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 9.6%. EPS of $1.78 for the same period compares to $1.73 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.07 billion, representing a surprise of -0.11%. The company delivered an EPS surprise of +0.57%, with the consensus EPS estimate being $1.77.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...